Difference between revisions of "Picoplatin"
Jump to navigation
Jump to search
(Undo revision 680675 by Asdfjklasdfjkl Revert Vandalism) |
|||
| Line 1: | Line 1: | ||
| − | + | '''Picoplatin''' is an [[intravenous]] [[platinum]]-based [[chemotherapy]] drug that has been designed to overcome the problems normally associated with resistance in chemotherapy regimes using platinum compounds. It was developed by a [[California]]n company, Poniard Pharmaceuticals, as a treatment for aggressive small cell lung cancer. | |
| + | |||
| + | [[Category:Medicine]] | ||
Latest revision as of 01:28, July 4, 2009
Picoplatin is an intravenous platinum-based chemotherapy drug that has been designed to overcome the problems normally associated with resistance in chemotherapy regimes using platinum compounds. It was developed by a Californian company, Poniard Pharmaceuticals, as a treatment for aggressive small cell lung cancer.